Immix Biopharma, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2021 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Immix Biopharma, Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from Q1 2021 to Q1 2023.
  • Immix Biopharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $178K, a 174% increase year-over-year.
  • Immix Biopharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $590K, a 167% increase year-over-year.
  • Immix Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $731K, a 53.4% increase from 2022.
  • Immix Biopharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $477K, a 198% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $590K $178K +$113K +174% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $477K $183K +$120K +189% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $357K $163K +$101K +164% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $256K $65.7K +$35K +114% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-12
Q1 2022 $221K $65.1K +$60.8K +1432% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $160K $63.2K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 $61.9K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $30.7K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $4.25K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.